UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities

Wegner, A; (2017) Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities. Immunotherapy , 9 (8) pp. 669-680. 10.2217/imt-2017-0028. Green open access

[thumbnail of Wegner_CAR-Tcell_Perspective_revision_clear_no_field_codes final.pdf]
Preview
Text
Wegner_CAR-Tcell_Perspective_revision_clear_no_field_codes final.pdf - Accepted Version

Download (437kB) | Preview

Abstract

Chimeric antigen receptor T-cell therapy has achieved highly promising results in clinical trials, particularly in B-cell malignancies. However, reports of serious adverse events including a number of patient deaths have raised concerns about safety of this treatment. Presently available preclinical models are not designed for predicting toxicities seen in human patients. Besides choosing the right animal model, careful considerations must be taken in chimeric antigen receptor T-cell design and the amount of T cells infused. The development of more sophisticated in vitro models and humanized mouse models for preclinical modeling and toxicity.

Type: Article
Title: Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities
Open access status: An open access version is available from UCL Discovery
DOI: 10.2217/imt-2017-0028
Publisher version: http://doi.org/10.2217/imt-2017-0028
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Science & Technology, Life Sciences & Biomedicine, Immunology, cancer immunotherapy, CAR, CD19, chimeric antigen receptor T cell, humanized mouse models, organoids, preclinical models, SEVERE COMBINED IMMUNODEFICIENCY, CYTOKINE RELEASE SYNDROME, ANTIBODY-LIKE IMMUNORECEPTORS, ACUTE LYMPHOBLASTIC-LEUKEMIA, HUMAN IMMUNE-SYSTEM, I CLINICAL-TRIAL, CAR-T, B-CELL, HUMANIZED MICE, ANTITUMOR EFFICACY
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/1560310
Downloads since deposit
564Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item